Trial · NCT05000216
Participant flow198
How many started, completed or left each group, period by period.
1 to 20 of 198
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Stage 1 | STARTED | Cohort A, Arm A1: Moderna mRNA-1273 + Continue IS (MMF or MPA) | 2 | |
| Stage 1 | STARTED | Cohort A, Arm A4: Moderna mRNA-1273 + Withhold IS (MMF or MPA) | 2 | |
| Stage 1 | STARTED | Cohort A, Arm A2: Pfizer-BioNTech + Continue IS (MMF or MPA) | 9 | |
| Stage 1 | STARTED | Cohort A, Arm A5: Pfizer-BioNTech + Withhold IS (MMF or MPA) | 10 | |
| Stage 1 | STARTED | Cohort A, Arm A6: Janssen + Withhold IS (MMF or MPA) | 2 | |
| Stage 1 | STARTED | Cohort B, Arm B1: Moderna mRNA-1273 + Continue IS (MTX) | 3 | |
| Stage 1 | STARTED | Cohort B, Arm B4: Moderna mRNA-1273 + Withhold IS (MTX) | 3 | |
| Stage 1 | STARTED | Cohort B, Arm B2: Pfizer-BioNTech + Continue IS (MTX) | 11 | |
| Stage 1 | STARTED | Cohort B, Arm B5: Pfizer-BioNTech + Withhold IS (MTX) | 11 | |
| Stage 1 | STARTED | Cohort C, Arm C1: Moderna mRNA-1273 + Continue IS (BCDT) | 41 | |
| Stage 1 | STARTED | Cohort C, Arm C2: Pfizer-BioNTech + Continue IS (BCDT) | 45 | |
| Stage 1 | STARTED | Cohort C, Arm C3: Janssen + Continue IS (BCDT) | 9 | |
| Stage 1 | STARTED | Cohort D, Arm D2: Alternative mRNA + Withhold IS (MMF or MPA) | 0 | |
| Stage 1 | STARTED | Cohort D, Arm D4: Sanofi-GSK + Withhold IS (MMF or MPA) | 0 | |
| Stage 1 | STARTED | Cohort E, Arm E2: Alternative mRNA + Withhold IS (MTX) | 0 | |
| Stage 1 | STARTED | Cohort E, Arm E4: Sanofi-GSK + Withhold IS (MTX) | 0 | |
| Stage 1 | STARTED | Cohort F, Arm F2: Alternative mRNA + Withhold IS (BCDT) | 0 | |
| Stage 1 | STARTED | Cohort F, Arm F3: Moderna mRNA-1273 + Withhold IS (BCDT) | 0 | |
| Stage 1 | STARTED | Cohort F, Arm F4: Sanofi-GSK + Withhold IS (BCDT) | 0 | |
| Stage 1 | STARTED | Cohort F, Arm F1: Janssen + Withhold IS (BCDT) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05000216/flow